Global Financial Private Client’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11
Closed -$1.87K 681
2025
Q1
$1.87K Hold
11
﹤0.01% 885
2024
Q4
$1.83K Hold
11
﹤0.01% 732
2024
Q3
$1.89K Hold
11
﹤0.01% 725
2024
Q2
$1.69K Hold
11
﹤0.01% 586
2024
Q1
$1.69K Hold
11
﹤0.01% 602
2023
Q4
$1.74K Hold
11
﹤0.01% 594
2023
Q3
$1.6K Hold
11
﹤0.01% 592
2023
Q2
$1.68K Hold
11
﹤0.01% 585
2023
Q1
$1.71K Hold
11
﹤0.01% 592
2022
Q4
$1.7K Hold
11
﹤0.01% 575
2022
Q3
$1.48K Hold
11
﹤0.01% 550
2022
Q2
$1.53K Hold
11
﹤0.01% 539
2022
Q1
$1.69K Hold
11
﹤0.01% 546
2021
Q4
$1.78K Hold
11
﹤0.01% 531
2021
Q3
$1.82K Hold
11
﹤0.01% 478
2021
Q2
$1.91K Hold
11
﹤0.01% 483
2021
Q1
$1.79K Hold
11
﹤0.01% 448
2020
Q4
$1.85K Hold
11
﹤0.01% 433
2020
Q3
$1.74K Buy
+11
New +$1.8K ﹤0.01% 416
2020
Q2
Sell
-348
Closed -$44.2K 518
2020
Q1
$44.2K Sell
348
-11
-3% -$1.57K 0.05% 221
2019
Q4
$53.4K Buy
+359
New +$49.3K 0.04% 231

Other funds holding FBT

Global Financial Private Client's FBT Position: Q2 2025 in Review

Global Financial Private Client sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 11 shares — an estimated $1.87K sold.

Global Financial Private Client first reported a position in FBT in Q4 2019 and held it in 21 quarters. The position peaked at $53.4K in Q4 2019. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

  • Global Financial Private Client reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 11 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $1.87K.
  • Global Financial Private Client first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 21 quarters.
  • Global Financial Private Client's First Trust NYSE Arca Biotechnology Index Fund position peaked at $53.4K in Q4 2019.
  • 250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.